Table 4 Initial therapy used to treat symptomatic patients diagnosed with Waldenström macroglobulinemia (WM) with only bone marrow involvement (BMWM) and those with extramedullary involvement (EMWM)
Type of therapy | EMWM (n = 106) | BMWM (n = 206) |
|---|---|---|
n (%) | n (%) | |
Treated for WM | ||
Yes | 94 (88.67) | 146 (70.87) |
Observation only | 8 (7.55) | 44 (21.36) |
Alternative medicine | 2 (1.89) | 9 (4.37) |
Missing data | 2 (1.89) | 7 (3.40) |
Initial treatment | ||
Chemotherapy | 20 (18.87) | 23 (11.17) |
Targeted therapy | 25 (23.58) | 79 (38.35) |
Combination | 49 (46.23) | 44 (21.36) |
Initial treatment with R | ||
Yes | 72 (67.92) | 118 (57.28) |
No | 22 (20.75) | 28 (13.59) |
Initial treatment with NA | ||
Yes | 35 (33.02) | 61 (29.61) |
No | 59 (55.67) | 85 (41.26) |